What Happened?
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels.
Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism.
The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Surgical Equipment & Consumables - Diversified company Solventum (NYSE: SOLV) jumped 7.4%. Is now the time to buy Solventum? Access our full analysis report here, it’s free.
- Dental Equipment & Technology company Envista (NYSE: NVST) jumped 6.3%. Is now the time to buy Envista? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Cardiology, Neurology, Vascular company ICU Medical (NASDAQ: ICUI) jumped 5.7%. Is now the time to buy ICU Medical? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Specialty company Globus Medical (NYSE: GMED) jumped 5.8%. Is now the time to buy Globus Medical? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Specialty company Enovis (NYSE: ENOV) jumped 10.2%. Is now the time to buy Enovis? Access our full analysis report here, it’s free.
Zooming In On Enovis (ENOV)
Enovis’s shares are somewhat volatile and have had 11 moves greater than 5% over the last year. But moves this big are rare even for Enovis and indicate this news significantly impacted the market’s perception of the business.
Enovis is down 17.1% since the beginning of the year, and at $36.70 per share, it is trading 30.3% below its 52-week high of $52.64 from May 2024. Investors who bought $1,000 worth of Enovis’s shares 5 years ago would now be looking at an investment worth $485.63.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.
